Boeing

Page: 8

FILE PHOTO: Ed Bastian, CEO of Delta Air Lines, speaks during a keynote address at the 2019 CES in Las Vegas
FILE PHOTO: Ed Bastian, CEO of Delta Air Lines, speaks during a keynote address at the 2019 Consumer Electronics Show (CES) in Las Vegas, Nevada, U.S. January 8, 2019. REUTERS/Steve Marcus/File Photo

April 9, 2019

ATLANTA (Reuters) – Delta Air Lines Inc Chief Executive Officer Ed Bastian said on Tuesday he was confident U.S. planemaker Boeing Co will solve issues related to its 737 MAX in the wake of two deadly crashes involving that airplane type.

Bastian, speaking at an aviation conference in Atlanta, also said Delta was “very interested” in Boeing’s proposed new mid-market airplane, though he said the world’s largest planemaker has put its focus into dealing with the crisis surrounding the MAX first.

(Reporting by Eric M. Johnson; Editing by Chizu Nomiyama)

Source: OANN

FILE PHOTO: People walk past an American Airlines logo at John F. Kennedy (JFK) airport in in New York
FILE PHOTO: People walk past an American Airlines logo on a wall at John F. Kennedy (JFK) airport in in New York November 27, 2013. REUTERS/Carlo Allegri/File Photo

April 9, 2019

(Reuters) – American Airlines Co Group Inc said on Tuesday its first-quarter revenue per available seat mile would be below its previous forecast due to the groundings of Boeing 737 MAX planes and the U.S. government shutdown.

The airline said it now expects https://www.sec.gov/Archives/edgar/data/4515/000000620119000014/a8kinvestorupdateex991q1-19.htm the closely followed measure of airline performance to be flat to up 1 percent compared with the prior forecast of flat to 2 percent growth.

(Reporting by Rachit Vats in Bengaluru; Editing by Arun Koyyur)

Source: OANN

FILE PHOTO: U.S. President Trump participates in Opportunity and Revitalization Council meeting at the White House in Washington
FILE PHOTO: U.S. President Donald Trump speaks during a meeting of the White House Opportunity and Revitalization Council in the Cabinet room at the White House in Washington, U.S., April 4, 2019. REUTERS/Kevin Lamarque/File Photo

April 9, 2019

WASHINGTON (Reuters) – U.S. President Donald Trump said on Tuesday the United States would impose tariffs on $11 billion of products from the European Union, a day after U.S. trade officials proposed a list of EU products to target as part of an ongoing aircraft dispute.

“The World Trade Organization finds that the European Union subsidies to Airbus has adversely impacted the United States, which will now put Tariffs on $11 Billion of EU products! The EU has taken advantage of the U.S. on trade for many years. It will soon stop!” Trump said in a post on Twitter.

The two sides have been locked in a years-long global trade dispute over mutual claims of illegal aid to plane giants, Netherlands-based Airbus and U.S.-based Boeing, to gain advantage in the world jet business.

The U.S. Trade Representative on Monday announced the planned products targeted in retaliation for European aircraft subsidies, with a final list expected this summer.

Meanwhile, the EU has started preparing to retaliate over Boeing subsidies, an EU official said on Tuesday.

The moves comes as the record subsidy dispute, which has been grinding its way through the WTO for almost 15 years, reaches a climax, with both sides in arbitration to decide the size of any countermeasures.

(Reporting by Susan Heavey; Editing by Mohammad Zargham and Bernadette Baum)

Source: OANN

FILE PHOTO: Traders work on the floor at the NYSE in New York
FILE PHOTO: Traders work on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo

April 9, 2019

By Sruthi Shankar

(Reuters) – U.S. stock index futures pointed to a flat open for Wall Street on Tuesday, as focus shifts to the first-quarter earnings season that kicks off later this week.

Global stocks were on edge after the United States threatened to slap tariffs on hundreds of European goods on Monday as retaliation for subsidies given to Airbus, while expectations of another cut to the IMF’s global growth forecasts added to worries.

The European Union has begun preparations to retaliate over Boeing Co subsidies, an EU official said.

Boeing’s shares were down 0.2% in premarket trading.

Earnings begin in earnest, with Delta Air Lines Inc reporting on Wednesday followed by big U.S. lenders later this week.

Investors, however, are bracing for the first quarter of contracting earnings since 2016. January-March profits for S&P 500 companies are expected to fall 2.3% from last year, according to Refinitiv data.

At 7:15 a.m. ET, Dow e-minis were down 6 points, or 0.02%. S&P 500 e-minis were down 2 points, or 0.07% and Nasdaq 100 e-minis were down 7.75 points, or 0.1%.

Among other early movers, Walt Disney Co inched up 0.9% after Cowen and Co raised its rating on the company to “outperform”, citing its strong pipeline of products.

United States Steel Corp fell 3.7% after Credit Suisse downgraded the stock to “underperform”.

(Reporting by Sruthi Shankar and Shreyashi Sanyal in Bengaluru; Editing by Anil D’Silva)

Source: OANN

FILE PHOTO: The Boeing logo is pictured at the LABACE fair in Sao Paulo
FILE PHOTO: The Boeing logo is pictured at the Latin American Business Aviation Conference & Exhibition fair (LABACE) at Congonhas Airport in Sao Paulo, Brazil August 14, 2018. REUTERS/Paulo Whitaker/File Photo

April 9, 2019

By Philip Blenkinsop and Tim Hepher

BRUSSELS/PARIS (Reuters) – The European Union has begun preparations to retaliate over Boeing subsidies, an EU official said on Tuesday, a day after Washington listed EU products it plans to hit with tariffs in their aircraft dispute.

The U.S. Trade Representative https://ustr.gov/about-us/policy-offices/press-office/press-releases/2019/april/ustr-proposes-products-tariff on Monday proposed a range of EU products ranging from large commercial aircraft and parts to dairy products and wine to target as retaliation for subsidies given to Airbus.

A European Commission source said on Tuesday the level of proposed U.S. countermeasures was “greatly exaggerated”, adding the amount of retaliation could only be determined by a World Trade Organization arbitrator.

“In the parallel Boeing dispute, the determination of EU retaliation rights is also coming closer and the EU will request the WTO-appointed arbitrator to determine the EU’s retaliation rights,” the Commision source said, adding the Commission was preparing so that it could take action after the arbitrator’s decision.

Airbus said it saw no legal basis for the U.S. move and warned of deepening transatlantic trade tensions.

The European Union is already facing U.S. tariffs on its steel and aluminum exports and U.S. President Donald Trump has repeatedly threatened to hit EU cars with punitive duties.

French Finance Minister Bruno Le Maire told a conference in Paris that the two sides needed to reach a friendly agreement.

“When I see the situation global growth is in, I don’t think we can afford to have a trade conflict even if only on the specific issues of the aircraft industry in the United States and Europe,” he said.

The two sides are closing in on the climax of a record subsidy dispute that has been grinding its way through the WTO for almost 15 years.

Both sides have won partial victories in claiming Airbus and Boeing received unlawful subsidies but disagree on the amount involved and whether each has complied with earlier WTO rulings.

MORE TIT-FOR-TAT?

The U.S. tariffs proposal put pressure on shares in European makers of aircraft and aerospace suppliers, wine, cheese and luxury goods.

At 0950 GMT, Airbus shares were down 1.6 percent. Airbus suppliers such as Safran and Leonardo lost between 1.0 percent and 1.2 percent. MTU Aero Engines was 2.5 percent weaker and Rolls-Royce down 1.3 percent.

“Get ready for more tit-for-tat scrapping to follow,” said John Woolfitt of London brokerage Atlantic Markets.

The WTO ruled last year that the European Union had failed to remove illegal subsidies for two aeroplane programs, the A350 and the A380.

The two sides are now in arbitration to decide the size of any countermeasures.

Airbus said it had taken measures to comply with the “relatively minor” elements outstanding regarding subsidies it had received.

German engineering lobby group the VDMA, which represents major exporters, said the European Union should swiftly move to negotiate a free trade agreement with the United States.

“Punitive tariffs are no solution to the problem; they only lead to a spiraling isolation,” Ulrich Ackermann, the VDMA’s head of foreign trade, said in a statement.

Germany is particularly apprehensive of possible U.S. tariffs on car imports. The United States is a major market for Volkswagen, Mercedes maker Daimler and BMW.

Moody’s said on Tuesday potential U.S. tariffs on imported autos and parts represented a significant risk to global growth and would hinder economic momentum in Germany, Japan and Korea.

(Reporting by Philip Blenkinsop; additional reporting by Tim Hepher, Richard Lough and Leigh Thomas in Paris, Helen Reid, Thyagaraju Adinarayan and Georgina Prodhan in London; Editing by Keith Weir)

Source: OANN

Part of the unpainted fuselage of a 737 Max aircraft at the Boeing factory in Renton
Part of the unpainted fuselage of a 737 Max aircraft at the Boeing factory in Renton, Washington, U.S., March 27, 2019. REUTERS/Lindsey Wasson

April 9, 2019

BEIJING (Reuters) – China has decided to accept an invitation to join the U.S. Federal Aviation Administration’s (FAA) review panel on the Boeing 737 MAX, an official of the Asian nation’s aviation regulator said on Tuesday.

The Civil Aviation Administration of China has decided to send experts to be part of the panel, the official, in the regulator’s media relations department, told Reuters.

Last week, the FAA said it was forming an international team to review the safety of the aircraft, grounded worldwide following two deadly crashes since October.

(Reporting by Stella Qiu and Brenda Goh; Editing by Clarence Fernandez)

Source: OANN

The Airbus logo is pictured at Airbus headquarters in Blagnac near Toulouse
The Airbus logo is pictured at Airbus headquarters in Blagnac near Toulouse, France, March 20, 2019. REUTERS/Regis Duvignau

April 9, 2019

PARIS (Reuters) – European planemaker Airbus said on Tuesday it saw no legal basis for the United States’ move towards imposing trade sanctions on its aircraft and warned of deepening trade tensions.

Washington on Monday proposed a list of EU products, from large commercial jets to dairy products and wine, on which to impose tariffs as retaliation for European aircraft subsidies.

The EU and the United States have fought for over a decade over mutual claims of illegal aid to plane giants Boeing and Airbus. Both sides have been judged by the WTO to have paid billions of dollars of subsidies to gain advantage, and asked to stop or face potential sanctions.

Airbus spokesman Rainer Ohler said the planemaker had taken measures to comply with the “relatively minor” outstanding requirements. U.S. talk of $11 billion worth of damage from EU subsidies to Airbus was excessive, he added.

“The amount is largely exaggerated and in any case will be defined by the WTO and not the U.S.” Ohler said.

Ohler said a WTO ruling last week against tax breaks for its U.S. rival Boeing should allow the EU to seek “even greater countermeasures.”

He said the ruling showed “no willingness at all on the Boeing side to comply and confirms they are clearly in contravention with WTO rules.”

A source at the European Commission said the EU was preparing for possible retaliation.

“All this is leading to unnecessary trade tensions and shows the only reasonable solution in this long trade dispute is a settlement,” added Ohler.

(Reporting by Tim Hepher; Writing by Richard Lough; Editing by Sudip Kar-Gupta/Keith Weir)

Source: OANN

FILE PHOTO: Employees walk by the end of a 737 Max aircraft at the Boeing factory in Renton
FILE PHOTO: Employees walk by the end of a 737 Max aircraft at the Boeing factory in Renton, Washington, U.S., March 27, 2019. REUTERS/Lindsey Wasson/File Photo

April 9, 2019

SHANGHAI (Reuters) – China Aircraft Leasing Group Holdings Ltd (CALC) on Tuesday said it has not put its order for 100 Boeing Co 737 MAX jets on hold nor had it suspended payment, rebutting an earlier report by the South China Morning Post (SCMP) newspaper.

The SCMP attributed its information to comments from CALC Chairman Chen Shuang. The Hong Kong-listed lessor said Chen was misquoted.

The Hong Kong-based newspaper later on Tuesday updated its story to quote CALC Chief Executive Mike Poon as saying the company had not stopped payment, but as deliveries were on hold, it did not need to make any payment for the time being.

“Our company currently does not have plans to change our Boeing aircraft orders and we have not suspended payment,” a spokeswoman for CALC told Reuters.

The Hong Kong-listed lessor, controlled by state-owned conglomerate China Everbright Group Co Ltd, placed an order for 50 737 MAX aircraft in June 2017 and later expanded the order.

A Boeing spokesman said the plane maker was focused on supporting customers and to ensure the 737 MAX’s return to commercial flight.

“China Aircraft Leasing Group Holdings has been and continues to be a valued customer and we are sorry for the disruption this situation has caused them,” the spokesman said.

(Reporting by Brenda Goh and Stella Qiu; Additional Reporting by Shanghai Newsroom; Editing by Christopher Cushing)

Source: OANN

Neilsen speaks at border security briefing near the US-Mexico border in California
Homeland Security Secretary Kirstjen Nielsen and U.S. President Donald Trump arrive to view a section of border wall in Calexico California, U.S., April 5, 2019. REUTERS/Kevin Lamarque

April 8, 2019

WASHINGTON (Reuters) – The White House said on Monday that President Donald Trump would replace the head of the U.S. Secret Service, a day after Trump asked for the resignation of Homeland Security Secretary Kirstjen Nielsen.

Nielsen and Trump had long clashed over immigration issues, and her departure came amid a surge in migrants from Central America at the southern U.S. border with Mexico.

Trump announced on Twitter that Kevin McAleenan, the current U.S. Customs and Border Protection commissioner, would become acting DHS secretary.

Randolph “Tex” Alles, the outgoing head of the Secret Service, said he had not been fired but that his departure was part of a broader shake-up of the Department of Homeland Security.

The White House said James Murray, a career Secret Service agent, would take over in May.

The Secret Service came under scrutiny after a Chinese woman carrying electronic devices was charged with bluffing her way through security checks at Trump’s Mar-a-Lago resort in Florida.

Trump’s White House has had the highest turnover of senior-level staff of the past five presidents, according to figures compiled by the Brookings Institution think tank.

Here are some senior figures who have been fired, quit or otherwise changed roles in the administration.

2019

Linda McMahon – The Republican fundraiser was one of Trump’s first Cabinet picks. She served as director of the Small Business Administration until March, when she resigned to join Trump’s re-election campaign. Trump nominated U.S. Treasurer Jovita Carranza to the position in April.

Clete Willems – A key figure in trade talks with China and a deputy to Trump’s top economic adviser, Larry Kudlow, Willems said in March he wanted to spend more time with his family.

Heather Wilson – The U.S. Air Force secretary, considered a top candidate to become the next defense secretary, decided to return to academia.

Bill Shine – Eight months after being hired as the White House communications director, he resigned to work on Trump’s re-election campaign. A source close to Trump said the president had lost confidence in the former Fox News executive.

2018

Jim Mattis – In a candid resignation letter that laid bare his growing divide with Trump over Syria and Afghanistan policies, the defense secretary abruptly quit, shocking allies and Congress. Trump named Mattis’ deputy, Patrick Shanahan, a former Boeing executive, to the role in an acting capacity soon afterward.

Ryan Zinke – Trump’s first interior secretary left at the end of 2018 amid investigations into his use of security details, chartered flights and a real estate deal.

John Kelly – A retired Marine Corps general, Kelly was hired as White House chief of staff to bring order to the chaotic Trump White House, but ultimately fell out with his boss. Trump named his budget director, Mick Mulvaney, to the job on an acting basis on Dec. 14.

Jeff Sessions – The former Republican U.S. senator from Alabama was finally forced out as attorney general on Nov. 7 after months of being attacked and ridiculed by the president for recusing himself from a special counsel probe into Russian interference in the 2016 presidential election. He was replaced briefly by Matthew Whitaker until William Barr was confirmed to the job.

Nikki Haley – The former South Carolina governor stepped down at the end of 2018 as U.S. ambassador to the United Nations. Trump first put forward State Department spokeswoman Heather Nauert as her successor, but she later withdrew. Trump has since nominated Republican donor and U.S. Ambassador to Canada Kelly Craft for the position.

Don McGahn – Trump said in August the White House counsel would leave amid strains between the two over the Russia probe.

Scott Pruitt – The Environmental Protection Agency chief quit on July 5 under fire over a series of ethics controversies.

David Shulkin – White House officials said on March 28 that the Veterans Affairs secretary would resign.

H.R. McMaster – The national security adviser was replaced on March 22 by John Bolton.

Rex Tillerson – The secretary of state was fired by Trump on March 13 after long-standing tension between them.

Gary Cohn – The National Economic Council director and former Goldman Sachs president said on March 5 he would resign. Trump picked Larry Kudlow to replace him.

Hope Hicks – The White House communications director, a long-serving and trusted Trump aide, resigned on Feb. 28.

Rob Porter – The White House staff secretary resigned in February after accusations of domestic abuse from former wives.

2017

Omarosa Manigault Newman – The former reality TV star was fired as assistant to the president in December.

Tom Price – The Health and Human Services secretary quit under pressure from Trump on Sept. 29 over travel practices.

Stephen Bannon – Trump’s chief strategist was fired by Trump in mid-August after clashing with White House moderates.

Anthony Scaramucci – The White House communications director was fired by Trump in July after 10 days on the job.

Reince Priebus – Replaced as chief of staff by Kelly, Priebus lost Trump’s confidence after setbacks in Congress.

Sean Spicer – Resigned as White House press secretary in July, ending a turbulent tenure.

Michael Dubke – Resigned as White House communications director in May.

James Comey – The FBI director, who led the Russia probe before the special counsel was appointed, was fired by Trump in May.

Michael Flynn – Resigned in February as Trump’s national security adviser. Flynn later pleaded guilty to lying to the FBI.

Sally Yates – Fired in January by Trump as acting attorney general.

(Reporting by Washington Newsroom; Editing by Kevin Drawbaugh, James Dalgleish and Peter Cooney)

Source: OANN

A couple of days ago I stumbled upon a radio interview where the topic was safety and government oversight. I had tuned in at the exact moment when the interviewee said the following:

Well, my experience of 30 years in Washington, D.C. is the same Ronald Reagan had – you know, trust but verify. And when bad things happen, you need to verify if what he is saying is correct. I certainly question that there’s not a cozy relationship. All anyone has to do is look at the revolving door in Washington, D.C., and this agency and the industry to realize that there is a cozy relationship. Now the question is, is that cozy relationship having an adverse impact on the safety decisions being made?

Before I could ascertain what they were discussing in the interview, my mind began to race. Could it be clean water, Round Up pesticide lawsuits, climate change, vaccine safety, the opioid crisis? My question was quickly answered. The forum was an interview on National Public Radio(NPR) with former National Transportation Safety Board (NTSB) chairman, James Hall, on the investigation into the recent tragedy of two Boeing 737 MAX airline crashes.  Upon a rewind of the interview, I kept hearing references to “revolving doors” and “cozy relationships.”

David Greene, host of the show, asked,

“But are you saying there are documents that Boeing has showing that they’re – that the company and, potentially the FAA, knew that there were some problems, some of the very problems that may have caused these accidents, and that they certified the aircraft anyway?”

Mr. Hall responded,

“…the process that we presently have is a self-certification process by the manufacturer of the safety of the aircraft… what has happened is that these decisions have been made in commissions and rulemakings dominated by the industry in Washington, D.C.”

As reported by NPR, the Federal Aviation Administration (FAA) left the safety testing of the plane to the manufacturing company (Boeing) and that this practice could be found “a lot” in the federal government. James Goodwin of the Center for Progressive Reform stated, “The American public would be surprised, and maybe even concerned, if they knew how widespread the practice of self-regulation was.” I wondered what implications this example might carry for aviation safety, agriculture, vaccine safety, and generally for the future of government oversight and scientific inquiry.

Toward the end of the interview, Mr. Greene from NPR stated that recently he had asked FAA head, Dan Elwell, some of the same questions. In one answer, Mr. Elwell responded, “the FAA is an agency that is based on data, and they very much make their decisions, including keeping those planes in the air, based on data.” Dan Elwell, is a former Vice President of the Aerospace Industries Association, representing the most powerful aerospace industry companies. There remain some very tough questions to be answered by the manufacturers of the airline industry, like Boeing, and the “cozy relationship” it and other industry members enjoy with the government agencies responsible for regulating its operations and overseeing its compliance with public safety. But, let’s move on from that thread of public air safety and pause for an overview of the opioid crisis facing the United States.

Alex exposes the globalist agenda that uses government agencies to cover up their crimes against the population.

Public Air Safety to the Opioid Crisis

Earlier in March, the 13th to be precise, I saved a copy of the transcript from an interview between David Greene and Brian Mann, an NPR associate, who has been following developments in some of the lawsuits around the nation’s opioid crisis. In its introduction to the interview NPR reported,

“The opioid epidemic claimed 70,000 lives in 2017. To put that in perspective, that is more than the number of people who died annually at the height of the HIV/AIDS epidemic. And the pharmaceutical industry is going to spend much of this year answering some hard questions. Many blame pharma for our country’s opioid crisis. And this year, big drug makers, as well as pharmacy chains, are facing more than 1,500 lawsuits filed by state and local governments. Billions of dollars are at stake, and so are reputations. Johnson & Johnson, Purdue Pharma, CVS – those are just some of the companies targeted in these lawsuits.”

The following are excerpts from the interview:

Greene: I mean that there are internal company documents that are being made public, and some of them have been controversial, you’ve been finding.

Mann: Purdue executives, for example, can be seen secretly acknowledging that their prescription opioids were far more addictive and dangerous than they were telling doctors. At the same time, company directives kept pushing sales, pushing the salespeople incredibly hard to get more opioids into the hands of vulnerable people, including seniors and military veterans….We’ve also learned that Purdue Pharma executives developed a secret plan they called Project Tango, which they allegedly hoped might help them profit again from the growing wave of opioid addiction. The idea here was to sell addiction treatment services to some of the same people addicted to products like their own OxyContin… Which means for more than a decade, no one in the wider public knew how serious the allegations against Purdue and these other drug companies were. But this time, states and cities suing these companies seem eager to sort of pull back the curtain… the drug industry has fought these disclosures at every turn. They describe the information in these documents as proprietary, basically arguing its corporate property. But as more and more information comes out, it’s making people angry.

On a related topic, Mr. Mann expressed:

But according to the drug company’s own documents, firms including Johnson & Johnson pushed unscientific theories about drug addiction. They did so allegedly to convince doctors to prescribe even more opioids after patients showed signs of dependency. David Armstrong, the reporter with ProPublica, says this kind of disclosure is making it harder for the industry to protect its image.

(Photo by Dr. Partha Sarathi Sahana, Flickr)

Government Agency Collusion

Government agency collusion with different industries, to me, represented nothing short of corruption. I was reminded of the tobacco industry and how the Phillip Morris tobacco company organized its Boca Raton Action Plan in 1988, in an effort to “diffuse and re-orient” the voices and initiatives of those fighting tobacco in favor of public health. Also, how the World Health Organization (WHO) itself colluded with legal experts and doctors in the United States in favor of the tobacco industry and against public health. From this fiasco was coined the expression “tobacco science;” i.e. “Science” done on behalf of an interest defending its profits, like the science conducted by a cigarette company showing that cigarettes are safe.

And speaking of the WHO, I was also reminded of the 2009 H1N1 (swine flu) “pandemic.” In the spring of 2010, the Council of Europe was investigating the role of the WHO in declaring the H1N1 pandemic. Dr. Wolfgang Wodarg, an epidemiologist who at one time was head of the Health Committee of the Council of Europe, expressed concerns that the contracts for the vaccine were mostly confidential arrangements between the WHO, individual member states and the companies producing the vaccine. In fact, numerous countries, including Germany, France, Italy and Great Britain, entered into contracts with the vaccine manufacturing companies prior to the WHO’s declaration of an H1N1 pandemic. The contracts obligated these countries to purchase swine flu vaccinations under one condition: that the WHO issue a pandemic flu alert.

Transformed Relationships

In his farewell speech to the citizenry, U. S. President Dwight D. Eisenhower poignantly expressed his concern regarding the future of science and its partnership with government, and government with industry, when he said:

…the free university, historically the fountainhead of free ideas and scientific discovery, has experienced a revolution in the conduct of research…The prospect of domination of the nation’s scholars by federal employment, project allocations, and the power of money is ever present and is gravely to be regarded. Yet, in holding scientific research and discovery in respect, as we should, we must also be alert to the equal and opposite danger that public policy could itself become the captive of a scientific-technological elite.

I kept wondering about the revolving doors, the collusion, industrial interests, and the science that was supposed to provide a foundation upon which to rest our confidence, our trust. How did we get here? The short answer, and quite possibly the simplest, might be the privatization of knowledge, or as some have called it, the “selling of science.” Or, maybe it’s the troubled matrimony of science and technology, where an applied and economic gain becomes the foundational rationale for present and future scientific endeavor. Such an environment raises serious questions as to the future of knowledge, the advancement of the sciences, and potential impacts on our economic, social, and public health.

Aristotle reminded us that “knowledge is virtue.” It has a value unto itself; a purpose that serves no particular master other than the rational development of inquiry and respective methods for the development of that knowledge. Here resided the principles of the classic universities, places where questions were explored, answered, and questioned again. This was the meaning of science – never settled – but forever moving toward a better, safer, healthier, and more advanced state of human affairs. But what happens to science when the scientist is tied to private industry, where the principle objective of private industry is defined by its stockholders interests, investments, and profits, where the same industry that manufactures the product for profit is also the industry responsible for generating the science determining the efficacy, effectiveness, and safety of its product?

In his book, Science in the Private Interest, Dr. Sheldon Krimsky writes,

“The responsibility of the scientist begins with discovery and ends with commercial applications. Universities exist mainly to provide labor for industry and to help industry turn knowledge into technology; technology into productivity; and productivity into profits.”

What Dr. Krimsky refers to as “public interest science as a model of knowledge for human welfare,” has been redefined, or more crudely speaking, undermined by the transformation of the relationship between scientists at universities, private industries with their scientists, and the “cozy relationships” that exist between the two. In the book To Profit or Not To Profit, authors Walter Powell and Jason Owens-Smith state,

“The changes underway at universities are the result of multiple forces: a transformation in of the nature policymakers and key constituents. These trends are so potent that there is little chance for reversing them-nor necessarily a rationale for doing so.”

These changes have been referred to as characteristic of the scientist as entrepreneur, or parts of what Sheila Slaughter and Larry Leslie explore in their book Academic Capitalism. In it, they write:

“We would expect that faculty as professionals participating in academic capitalism would begin to move away from values such as altruism and public service, toward market values.”

The Transformation of Science and Scientists

The transformation of science and scientists that are lured into and seek financial support from private industry for any number of research-to-market projects has become an all too familiar scenario with potentially devastating consequences.

Most recently, the parents of one of the victims of the Egyptian Boeing airline, filed suit against Boeing and the Rosemont airline parts manufacturing industry. Reuters report states that:

Thursday’s complaint accuses Boeing of putting “profits over safety” and said the U.S. Federal Aviation Administration must also be held accountable for certifying the 737 MAX. 

However, reports Reuters: “Legal experts say these cases face high hurdles since government officials and agencies are generally immune from civil lawsuits.”

Under the current science-to-market model, government oversight of any number of products, from airplanes, to drugs, to tobacco, and more, continues to demonstrate a complacency that favors market-driven profits over public safety. This reality should alarm anyone and all. What if, as some of the legal experts above claim, a U.S. citizen has no right to hold industry responsible for assurances of safety because those industries are tied to government agencies, or because those agencies derive profits or “benefits” from the “cozy relationships?” If you believe that the FAA and the FDA need to come clean regarding the “revolving door” and “cozy relationships” that experts have indicated exist between both agencies and private industry, why would we not consider the same for the Centers for Disease Control and Prevention (CDC)?

Arguably, a profoundly vivid parallel is seen in the policies and practices of mandatory vaccination and informed consent. Over the many years studying vaccination theory and practice, I discovered a disturbing similar pattern – the “revolving door” between the CDC and private pharmaceutical manufacturing companies, the conflicts of interest where different committees and their members are given waivers protecting conflicts of interest, payoffs to doctors for administering vaccines, fast-tracking of vaccines and safety studies with no use of double-blind placebo studies, and the very “cozy relationship” between members of Congress, “big pharma,” the CDC and the Food and Drug Administration (FDA).

In 1986, Congress passed the National Childhood Vaccine Injury Act (NCVIA). For years families had been suing vaccine manufacturers for injuries their children suffered at the hands of vaccines. Threatening to discontinue vaccine production, the vaccine manufacturers asked for government assurances that their products would go forward unhindered. The 1986 law took all liability away from the manufacturers of vaccines, making it impossible to sue the industry. The same law stipulated that every two years the Department of Health and Human Services (HHS) would submit a report to Congress on the state of vaccine safety. It was during this time that the numbers and doses of vaccines began a dramatic increase.

In 2017 Robert F. Kennedy Jr. and Del Bigtree of the Informed Consent Action Network (ICAN) filed a suit before the U.S. Federal Court for the Southern District of New York. On July 27, 2018, HHS admitted the following before the court:

The [Department]’s searches for records did not locate any records responsive to your request. Department of Health and Human Services (HHS) Immediate Office of the Secretary (IOS) conducted a thorough search of its document tracking systems. The department also conducted a comprehensive review of all relevant indexes of HHS secretarial correspondence records maintained at Federal record centers that remain in the custody of HHS. These searches did not locate records responsive to your request, or indications that records responsive to your request and in the custody of HHS are located at Federal record centers.

Today in the United States, political, medical, and mass media leadership, infused by the interests of vaccine manufacturers, are currently engaged in a massive campaign to silence dialogue, ban books and websites, avoid debates, and impose that vaccines become mandatory for all with no respect to informed consent, religious beliefs, medical conditions, or personal conscience. Writing on a recent measles outbreak in Rockland County, New York, Celeste McGovern remarks,

“People, like those in Rockland County, don’t avoid vaccines because they are misled by “fake” news and Facebook – but because of the real stories of corporate greed and political cover-up and vaccine-injured children that are shared on those platforms. The data bears them out. There are millions of them.”

The very thought that censorship would become an instrument of intimidation, humiliation, a threat, and a practice violating human rights, should make anyone shiver. But maybe more importantly, the unbridled and crass censorship we are witnessing today on the topic of mandatory vaccination, its effectiveness and safety, should leave us asking: How is it possible that censorship becomes a principal upon which public policy and social interaction are defined in a democracy? Will the violation of the right to informed consent become the new paradigm applied to air travel, medications, vaccination, food, and more?

Personally, and professionally, I see nothing edifying and positive coming from the censorship of those that question. Boeing has explaining to do, as does the FAA. Furthermore, Johnson & JohnsonPurdueCVS and the FDA, owe the people an explanation. Likewise, the HHS, CDC, and pharma owe the people many explanations about the safety of vaccines.

This is no time for silence.

The viewpoints expressed here do not necessarily represent those of Infowars.

Brian Stelter is famous for complaining too much.

Source: InfoWars


Current track

Title

Artist